当前位置: 首页 > 详情页

Icariin Promotes Survival, Proliferation, and Differentiation of Neural Stem Cells In Vitro and in a Rat Model of Alzheimer's Disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, China [2]National Clinical Research Center for Geriatric Diseases, Beijing 100053, China [3]Beijing Engineering Research Center for Nervous System Drugs, Beijing 100053, China [4]Beijing Institute for Brain Disorders, Beijing 100053, China [5]Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, China
出处:
ISSN:

摘要:
Alzheimer's disease (AD) involves the degeneration of cholinergic neurons in the basal forebrain. Neural stem cell (NSC) transplantation has emerged as a promising therapeutic approach for treating AD. Icariin (ICA) is the main active component in Epimedium, a traditional Chinese herb. The purpose of the present study was to investigate the effects and mechanisms of ICA on the proliferation and differentiation of NSCs in the basal forebrain of a fimbria-fornix transection (FFT) rat model. In the present study, ICA promoted the survival, proliferation, and migration of NSCs in vitro. In FFT rats, ICA promoted the proliferation and differentiation of NSCs into neurons and increased the number of cholinergic neurons in the MS and VDB of the basal forebrain. These results suggest that combination therapy of ICA oral administration and NSC transplantation may provide a new potential and effective approach for AD therapy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 3 区 细胞与组织工程
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 细胞与组织工程
JCR分区:
出版当年[2019]版:
Q2 CELL & TISSUE ENGINEERING
最新[2023]版:
Q2 CELL & TISSUE ENGINEERING

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, China [2]National Clinical Research Center for Geriatric Diseases, Beijing 100053, China [3]Beijing Engineering Research Center for Nervous System Drugs, Beijing 100053, China [4]Beijing Institute for Brain Disorders, Beijing 100053, China [5]Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, China
通讯作者:
通讯机构: [1]Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, China [2]National Clinical Research Center for Geriatric Diseases, Beijing 100053, China [3]Beijing Engineering Research Center for Nervous System Drugs, Beijing 100053, China [4]Beijing Institute for Brain Disorders, Beijing 100053, China [5]Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院